These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 2419121)
21. Purification of a high molecular weight somatomedin binding protein from human plasma. Enberg G Biochem Biophys Res Commun; 1986 Feb; 135(1):178-82. PubMed ID: 2420327 [TBL] [Abstract][Full Text] [Related]
22. Insulin-like growth factor (IGF) binding protein from human decidua inhibits the binding and biological action of IGF-I in cultured choriocarcinoma cells. Ritvos O; Ranta T; Jalkanen J; Suikkari AM; Voutilainen R; Bohn H; Rutanen EM Endocrinology; 1988 May; 122(5):2150-7. PubMed ID: 2452077 [TBL] [Abstract][Full Text] [Related]
24. Somatomedin-C/insulin-like growth factor I-binding proteins in human amniotic fluid and in fetal and postnatal blood: evidence of immunological homology. D'Ercole AJ; Drop SL; Kortleve DJ J Clin Endocrinol Metab; 1985 Oct; 61(4):612-7. PubMed ID: 2411754 [TBL] [Abstract][Full Text] [Related]
25. Soluble 34K binding protein inhibits the binding of insulin-like growth factor I to its cell receptors in human secretory phase endometrium: evidence for autocrine/paracrine regulation of growth factor action. Rutanen EM; Pekonen F; Mäkinen T J Clin Endocrinol Metab; 1988 Jan; 66(1):173-80. PubMed ID: 2961785 [TBL] [Abstract][Full Text] [Related]
26. Purification from human cerebrospinal fluid of insulin-like growth factor binding proteins (IGFBPs). Isolation of IGFBP-2, an altered form of IGFBP-3 and a new IGFBP species. Roghani M; Segovia B; Whitechurch O; Binoux M Growth Regul; 1991 Sep; 1(3):125-30. PubMed ID: 1726837 [TBL] [Abstract][Full Text] [Related]
27. Human preovulatory follicular fluid, luteinized cells of hyperstimulated preovulatory follicles, and corpus luteum contain placental protein 12. Seppälä M; Wahlström T; Koskimies AI; Tenhunen A; Rutanen EM; Koistinen R; Huhtaniemi I; Bohn H; Stenman UH J Clin Endocrinol Metab; 1984 Mar; 58(3):505-10. PubMed ID: 6363439 [TBL] [Abstract][Full Text] [Related]
28. Characterization of a protein in mid-term human amniotic fluid which reacts in the somatomedin-C radioreceptor assay. Chochinov RH; Mariz IK; Hajek AS; Daughaday WH J Clin Endocrinol Metab; 1977 May; 44(5):902-8. PubMed ID: 870516 [TBL] [Abstract][Full Text] [Related]
29. Affinity-labeled somatomedin-C receptors and binding proteins from the human fetus. Grizzard JD; D'Ercole AJ; Wilkins JR; Moats-Staats BM; Williams RW J Clin Endocrinol Metab; 1984 Mar; 58(3):535-43. PubMed ID: 6198334 [TBL] [Abstract][Full Text] [Related]
30. Purification and characterization of a unique high molecular weight form of insulin-like growth factor II. Gowan LK; Hampton B; Hill DJ; Schlueter RJ; Perdue JF Endocrinology; 1987 Aug; 121(2):449-58. PubMed ID: 2439316 [TBL] [Abstract][Full Text] [Related]
31. Purification and characterization of a fetal somatomedin from the sheep: similarity to insulin-like growth factor II. Hey AW; Browne CA; Thorburn GD Endocrinology; 1988 Jan; 122(1):12-21. PubMed ID: 3335201 [TBL] [Abstract][Full Text] [Related]
32. Immunoreactive somatomedin-C/insulin-like growth factor I and its binding protein in human milk. Baxter RC; Zaltsman Z; Turtle JR J Clin Endocrinol Metab; 1984 Jun; 58(6):955-9. PubMed ID: 6202711 [TBL] [Abstract][Full Text] [Related]
33. Elevated levels of a somatomedin-binding protein PP12 in patients with ovarian cancer. Iino K; Seppälä M; Heinonen PK; Sipponen P; Rutanen EM Cancer; 1986 Nov; 58(10):2294-7. PubMed ID: 2428459 [TBL] [Abstract][Full Text] [Related]
34. Purification of a 31,000-dalton insulin-like growth factor binding protein from human amniotic fluid. Isolation of two forms with different biologic actions. Busby WH; Klapper DG; Clemmons DR J Biol Chem; 1988 Oct; 263(28):14203-10. PubMed ID: 2971653 [TBL] [Abstract][Full Text] [Related]
35. Isolation of an inhibitory insulin-like growth factor (IGF) binding protein from bone cell-conditioned medium: a potential local regulator of IGF action. Mohan S; Bautista CM; Wergedal J; Baylink DJ Proc Natl Acad Sci U S A; 1989 Nov; 86(21):8338-42. PubMed ID: 2479022 [TBL] [Abstract][Full Text] [Related]
36. N-terminal sequence analysis of human placental protein 14, purified in high yield from decidual cytosol. Westwood OM; Chapman MG; Totty N; Philp R; Bolton AE; Lazarus NR J Reprod Fertil; 1988 Mar; 82(2):493-500. PubMed ID: 3361484 [TBL] [Abstract][Full Text] [Related]
37. Recognition of insulin-like-growth-factor-binding proteins in serum and amniotic fluid by an antiserum against a low-molecular-mass insulin-like-growth-factor-inhibitor/binding protein. Ooi GT; Herington AC Biochem J; 1990 May; 267(3):615-20. PubMed ID: 1692703 [TBL] [Abstract][Full Text] [Related]
38. Production of the rat type 1 insulin-like growth factor-binding protein by well differentiated H4EIIC3 hepatoma cells: identification, purification, and N-terminal amino acid analysis. Unterman TG; Oehler DT; Gotway MB; Morris PW Endocrinology; 1990 Aug; 127(2):789-97. PubMed ID: 2164920 [TBL] [Abstract][Full Text] [Related]
39. Human 'pregnancy-associated endometrial alpha 1-globulin', an insulin-like growth factor-binding protein: immunohistological localization in the decidua and placenta during pregnancy employing monoclonal antibodies. Waites GT; James RF; Bell SC J Endocrinol; 1989 Feb; 120(2):351-7. PubMed ID: 2466932 [TBL] [Abstract][Full Text] [Related]
40. Immunochemical and biochemical relationship between human pregnancy-associated secreted endometrial alpha 1- and alpha 2-globulins (alpha 1- and alpha 2-PEG) and the soluble placental proteins 12 and 14 (PP12 and PP14). Bell SC; Bohn H Placenta; 1986; 7(4):283-94. PubMed ID: 2428028 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]